Jianlin Liu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center, Beijing Graphene Institute, Nanchong Central Hospital, BGI Research · ORCID：0000-0003-3732-5143

发表论文 64 篇 · 总被引 330 次 · h-index 9

代表论文

• The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma (2025 · Leukemia · 被引 13)
• Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy (2025 · Cell Death and Disease · 被引 5)
• Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma (2025 · Leukemia · 被引 4)
• Single cell spatial transcriptomics track the evolutionary hierarchy and microenvironment remodeling during breast carcinoma invasion (2026 · Nature Communications)
• Evaluating the impact of treatment timing with recombinant human thrombopoietin for cancer treatment–induced thrombocytopenia: A retrospective cohort study. (2026 · Journal of Clinical Oncology)
• Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance (2025)